Biotechnology Assets (Spain) Technical Analysis
| BST Stock | 0.20 0.02 9.09% |
As of the 6th of February, Biotechnology Assets shows the Risk Adjusted Performance of (0.14), standard deviation of 3.44, and Mean Deviation of 2.61. Biotechnology Assets technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biotechnology Assets Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biotechnology, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiotechnologyBiotechnology |
Biotechnology Assets 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Assets' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Assets.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Biotechnology Assets on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Biotechnology Assets SA or generate 0.0% return on investment in Biotechnology Assets over 90 days. Biotechnology Assets is related to or competes with International Consolidated, Naturhouse Health, Energy Solar, Arteche Lantegi, and Hispanotels Inversiones. More
Biotechnology Assets Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Assets' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Assets SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 15.34 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 5.26 |
Biotechnology Assets Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Assets' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Assets' standard deviation. In reality, there are many statistical measures that can use Biotechnology Assets historical prices to predict the future Biotechnology Assets' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.70) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | 2.06 |
Biotechnology Assets February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | 2.07 | |||
| Mean Deviation | 2.61 | |||
| Coefficient Of Variation | (492.74) | |||
| Standard Deviation | 3.44 | |||
| Variance | 11.8 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (0.70) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | 2.06 | |||
| Maximum Drawdown | 15.34 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 5.26 | |||
| Skewness | (0.09) | |||
| Kurtosis | 0.0254 |
Biotechnology Assets Backtested Returns
Biotechnology Assets secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19 % return per unit of risk over the last 3 months. Biotechnology Assets SA exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotechnology Assets' Mean Deviation of 2.61, standard deviation of 3.44, and Risk Adjusted Performance of (0.14) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Biotechnology Assets are expected to decrease at a much lower rate. During the bear market, Biotechnology Assets is likely to outperform the market. At this point, Biotechnology Assets has a negative expected return of -0.65%. Please make sure to confirm Biotechnology Assets' treynor ratio and the relationship between the skewness and day typical price , to decide if Biotechnology Assets performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.23 |
Weak reverse predictability
Biotechnology Assets SA has weak reverse predictability. Overlapping area represents the amount of predictability between Biotechnology Assets time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Assets price movement. The serial correlation of -0.23 indicates that over 23.0% of current Biotechnology Assets price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biotechnology Assets technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biotechnology Assets Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biotechnology Assets volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Biotechnology Assets Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biotechnology Assets SA on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biotechnology Assets SA based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biotechnology Assets price pattern first instead of the macroeconomic environment surrounding Biotechnology Assets. By analyzing Biotechnology Assets's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biotechnology Assets's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biotechnology Assets specific price patterns or momentum indicators. Please read more on our technical analysis page.
Biotechnology Assets February 6, 2026 Technical Indicators
Most technical analysis of Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biotechnology from various momentum indicators to cycle indicators. When you analyze Biotechnology charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | 2.07 | |||
| Mean Deviation | 2.61 | |||
| Coefficient Of Variation | (492.74) | |||
| Standard Deviation | 3.44 | |||
| Variance | 11.8 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (0.70) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | 2.06 | |||
| Maximum Drawdown | 15.34 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 5.26 | |||
| Skewness | (0.09) | |||
| Kurtosis | 0.0254 |
Biotechnology Assets February 6, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biotechnology stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 17,455 | ||
| Daily Balance Of Power | (1.00) | ||
| Rate Of Daily Change | 0.91 | ||
| Day Median Price | 0.20 | ||
| Day Typical Price | 0.20 | ||
| Price Action Indicator | (0.01) |
Complementary Tools for Biotechnology Stock analysis
When running Biotechnology Assets' price analysis, check to measure Biotechnology Assets' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotechnology Assets is operating at the current time. Most of Biotechnology Assets' value examination focuses on studying past and present price action to predict the probability of Biotechnology Assets' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotechnology Assets' price. Additionally, you may evaluate how the addition of Biotechnology Assets to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |